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ON RISKS OF HOSPITALISATION FOR PATIENTS 
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OBJECTIVES: Adverse drug reactions to oral anticoagulants are
a cause of signiﬁcant morbidity. Treatment decisions will depend
on effective means of risk stratiﬁcation and a better under-
standing of changes that occur in the immediate period just
before an event. METHODS: Cox proportional hazards model-
ling and the case crossover methodology were applied to deter-
mine the hazards associated with the outcome of hospitalisation
due to bleeding or over-anticoagulation. The study population
comprised an inception cohort of 735, accumulating 583
patients years follow up. Under Cox proportional hazards mod-
elling pre-speciﬁed clinical and laboratory variables were tested,
including measures of quality of anticoagulation. Under the case-
crossover methodology changes in biochemical, haematological,
anticoagulation parameters, drug exposures, and their relation
to outcome were analysed by conditional logistic regression
analysis. Measurements from a 3-month case window immedi-
ately before the outcome event were compared to a control
window four to six months before the outcome event. In both
analyses factors univariately associated at p < 0.3 were consid-
ered in a multivariate backward-stepwise analysis. RESULTS:
Under multivariate Cox proportional hazards modelling four
variables were found to be signiﬁcantly and independently cor-
related with the outcome; % days over INR 4.4 (p < 0.001),
history of malignancy (p = 0.048), history of any bleed (p <
0.001), number of current comorbidities (p = 0.046). The case
crossover analysis suggested that patients experiencing an
outcome event were more likely to have spent time above INR
4.4 in the case period just before the event compared to the
control period. For every increase of 1% in the time spent above
INR 4.4 the odds of an event increased by 27% (95% CI
4%–54%). CONCLUSION: This study provides further evi-
dence of the importance of monitoring and reporting time spent
over INR 4.4 to minimise the risk of adverse outcomes to 
warfarin therapy.
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USING A PATTERN MIXTURE MODEL TO UNDERSTAND THE
IMPACT OF NON-RANDOM MISSING DATA IN HEALTH-
RELATED QUALITY OF LIFE AMONG PATIENTS
UNDERGOING NON-CARDIAC VASCULAR SURGERY
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OBJECTIVE: Non-randomness of missing data in longitudinal
health-related quality of life (HRQL) studies causes potential
bias of estimates using conventional generalized linear model
(GLM). The study objective was to compare a pattern mixture
model (PMM) with GLM. METHODS: HRQL data were col-
lected using the SF-12 acute at baseline and postoperative Day
30 as part of a clinical trial assessing perioperative myocardial
ischemic injury (PMII) in high-risk noncardiac vascular surgery
patients. A PMM, where the indicator variable of drop-out and
the interaction term of drop-out and the presence of PMII event
were included as covariates, was ﬁtted using physical component
scores (PCS) of SF-12 as the outcome variable. The main pre-
dictor was the presence of PMII event adjusted for a host of
control variables. This PMM was compared with a GLM where
a change in PCS on SF-12 was used as a dependent variable.
RESULTS: Of the 370 subjects in the U.S. clinical population,
229 subjects provided information on the SF-12 at baseline and
195 subjects at Day 30. Mean PCS were 30.6 (SD = 10.7) at
baseline and 32.8 (10.6) at Day 30. Drop-out was not indepen-
dent of the presence of PMII event (p = 0.0085). With the GLM
using only completed cases (N = 190), an unexpected result
emerged; the presence of PMII event was positively associated
with improvement in the PCS of SF-12. In contrast, PMM (N =
229) indicated a more realistic result of a change in direction
that, although statistically insigniﬁcant (p = 0.11), reﬂected a
detrimental effect on PCS in the presence of a PMII event. CON-
CLUSION: GLM on complete data can give a spurious result
when sicker patients are more likely to be excluded from analy-
sis. While the PMM provided a logical direction of effect, a
longer follow-up may have been necessary to detect a statisti-
cally signiﬁcant and noticeable improvement in the PCS.
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ASSESSING THE LIKELIHOOD OF FRACTURE WITH ORAL
ANTI-SPASTICITY MEDICATIONS:A CASE-CONTROL STUDY
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OBJECTIVES: To estimate the odds ratio of hip or vertebral
fracture associated with oral anti-spasticity medications in a 
California Medicaid stroke/spasticity population. METHODS:
A case-control design matched each hip or vertebral fracture
patient to ﬁve patients without fracture on date of ﬁrst pre-
scription of oral spasticity medication. Oral spasticity medica-
tions were grouped according to their sedative qualities (light
headedness, somnolence or drowsiness). Logistic regression was
used to estimate adjusted odds ratios of fractures for medication
groups while controlling for patient demographics, comorbidity,
and other concurrent medications, through a propensity score
approach. RESULTS: The adjusted odds ratio of having a hip 
or vertebral fracture for patients using medication classiﬁed in
the somnolence group (Dronabinol, Lamotrigine, Riluzole or
Tizanidine) was 1.88 (p = 0.003). The odds ratio was reduced
to 1.65 after propensity score adjustment, but remained statisti-
cally signiﬁcant (p = 0.024). Light headedness and drowsiness
medication groups did not show a signiﬁcant effect on fracture.
Concurrent use of Diazepam, a member of the drowsiness 
medication group, was individually associated with the likeli-
hood of fracture (raw odds ratio = 1.48, p = 0.002; odds ratio
after propensity score adjustment = 1.39, p = 0.014). CON-
CLUSIONS: Care should be taken when prescribing sedating
oral spasticity agents in elderly stroke patients.
HEALTH POLICY
PHP1
RETAIL PRICES DECREASED 30% IN FINLAND IN 1994–2003
EVEN BEFORE INTRODUCTION OF GENERIC
SUBSTITUTION:A COHORT ANALYSIS
Jormanainen V, Hahl J, Eränkö P
GlaxoSmithKline Oy, Espoo, Finland
OBJECTIVES: We followed the retail prices of the year 1994
cohort of new chemical entities (“the 1994 NCE cohort”) in
Finland until March 15, 2003, before the introduction of generic
and parallel import substitution on April 1, 2003. METHODS:
The 1994 NCE cohort did not have any sales in 1993 by deﬁn-
